Skip to main content

Table 1 Characteristics of the patient's population according to the genotypes (N = 130)

From: Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Characteristics

All

Genotype 1

Genotype 3

 

(N = 130)

(N = 90)

(N = 40)

Men n (%)

94 (72)

63 (70)

31 (77)

Race

   

Caucasian n (%)

117 (90)

79 (87)

38 (95)

Age median, years

48

46.5

49

Alcohol abuse present, n (%)

22 (17)

15 (16)

7 (17)

Possible acquisition route n (%)

   

IVDU

28 (21)

15 (16)

13 (32)

Parenteral

44 (33)

33 (36)

11 (27)

Parenteral and IVDU

5 (4)

3 (3)

2 (5)

Unknown

53 (40)

39 (43)

14 (35)

Leukocytes (× 104 cells/L)

6.35

6.35

5.94

median [interval]

[2.7; 19]

[2.7; 19]

[3.9; 13]

Neutrophilis (× 106 cells/L)

3.38

3.28

5.94

median [interval]

[0.33; 9.44]

[0.33; 7.8]

[0.8; 9.44]

Hemoglobin (mg/dL)

15.3

15.5

13.5

median [interval]

[2.7; 19]

[2.7; 19]

[3.9; 13]

Platelets (× 103/mm3)

194

184

200

median [interval]

[80; 345]

[83; 345]

[80; 275]

q ALT*

1.85

1.85

2.1

median [interval]

[0.7; 9.3]

[0.7; 5.1]

[0.9; 9.3]

  1. qALT* = U/NUL